The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings
CNS Neuroscience & Therapeutics · 2024-10 · 30 (10)
DOI: 10.1111/cns.70091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 26.10.2024. Verfasst von Jianshe Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Harbin Institute of Physical Education, Harbin, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Alzheimer Disease, Neuroinflammatory Diseases. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Project for Postgraduate Students of Heilongjiang University of Traditional Chinese Medicine.
Themen: Demenz
Abstract (Originalsprache)
Background and Purpose Alzheimer's disease (AD) is characterized by progressive cognitive decline and neuronal loss, commonly linked to amyloid‐β plaques, neurofibrillary tangles, and neuroinflammation. Recent research highlights the gut microbiota as a key player in modulating neuroinflammation, a critical pathological feature of AD. Understanding the role of the gut microbiota in this process is essential for uncovering new therapeutic avenues and gaining deeper insights into AD pathogenesis.
Methods
This review provides a comprehensive analysis of how gut microbiota influences neuroinflammation and glial cell function in AD. A systematic literature search was conducted, covering studies from 2014 to 2024, including reviews, clinical trials, and animal studies. Keywords such as “gut microbiota,” “Alzheimer's disease,” “neuroinflammation,” and “blood–brain barrier” were used.
Results
Dysbiosis, or the imbalance in gut microbiota composition, has been implicated in the modulation of key AD‐related mechanisms, including neuroinflammation, blood–brain barrier integrity, and neurotransmitter regulation. These disruptions may accelerate the onset and progression of AD. Additionally, therapeutic strategies targeting gut microbiota, such as probiotics, prebiotics, and fecal microbiota transplantation, show promise in modulating AD pathology.
Conclusions
The gut microbiota is a pivotal factor in AD pathogenesis, influencing neuroinflammation and disease progression. Understanding the role of gut microbiota in AD opens avenues for innovative diagnostic, preventive, and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harbin Institute of Physical Education, Harbin, Heilongjiang Province, China.
- Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China.
ORCID-Profile: Jianshe Yang, Junyi Liang
Förderung
- Innovative Research Project for Postgraduate Students of Heilongjiang University of Traditional Chinese Medicine
Zitieren
APA
Yang, J., Liang, J., Hu, N., He, N., Liu, B., Liu, G., & Qin, Y. (2024). The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings. CNS Neuroscience & Therapeutics, 30(10). https://doi.org/10.1111/cns.70091
Vancouver
Yang J, Liang J, Hu N, He N, Liu B, Liu G, et al. The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings. CNS Neuroscience & Therapeutics. 2024;30(10). doi:10.1111/cns.70091
BibTeX
@article{Yang2024,
author = {Yang, Jianshe and Liang, Junyi and Hu, Niyuan and He, Ningjuan and Liu, Bin and Liu, Guoliang and Qin, Ying},
title = {The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {10},
doi = {10.1111/cns.70091}
}
EUVIMED